Jane Donaldson

1.7k total citations · 1 hit paper
14 papers, 1.2k citations indexed

About

Jane Donaldson is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jane Donaldson has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jane Donaldson's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Jane Donaldson is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Jane Donaldson collaborates with scholars based in Canada, United Kingdom and Germany. Jane Donaldson's co-authors include Laurie H. Sehn, Joseph M. Connors, Randy D. Gascoyne, Richard Klasa, Mukesh Chhanabhai, Karamjit Gill, Judy Sutherland, C. P. Fitzgerald, John J. Spinelli and Kenneth S. Wilson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Cell Science.

In The Last Decade

Jane Donaldson

14 papers receiving 1.1k citations

Hit Papers

Introduction of Combined CHOP Plus Rituximab Therapy Dram... 2005 2026 2012 2019 2005 200 400 600

Peers

Jane Donaldson
Hyeon Seok Eom South Korea
Rodney R. Miles United States
Kena C. Miller United States
L Mangoni Italy
JHJM van Krieken Netherlands
L. Austin Doyle United States
Ira Gupta United States
E.D. Kreuser Germany
Hyeon Seok Eom South Korea
Jane Donaldson
Citations per year, relative to Jane Donaldson Jane Donaldson (= 1×) peers Hyeon Seok Eom

Countries citing papers authored by Jane Donaldson

Since Specialization
Citations

This map shows the geographic impact of Jane Donaldson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Donaldson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Donaldson more than expected).

Fields of papers citing papers by Jane Donaldson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Donaldson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Donaldson. The network helps show where Jane Donaldson may publish in the future.

Co-authorship network of co-authors of Jane Donaldson

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Donaldson. A scholar is included among the top collaborators of Jane Donaldson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Donaldson. Jane Donaldson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Moccia, Alden A., Jane Donaldson, Mukesh Chhanabhai, et al.. (2012). International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era. Journal of Clinical Oncology. 30(27). 3383–3388. 126 indexed citations
2.
3.
Donaldson, Jane, Mukesh Chhanabhai, Paul Hoskins, et al.. (2009). The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.. Blood. 114(22). 1554–1554. 4 indexed citations
4.
5.
Sehn, Laurie H., Jane Donaldson, Mukesh Chhanabhai, et al.. (2005). Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia. Journal of Clinical Oncology. 23(22). 5027–5033. 744 indexed citations breakdown →
6.
Sehn, Laurie H., Jane Donaldson, C. P. Fitzgerald, et al.. (2004). Rapid Infusion Rituximab in Combination with Steroid Containing Chemotherapy Can Be Given Safely and Substantially Reduces Resource Utilization.. Blood. 104(11). 1407–1407. 12 indexed citations
7.
Fears, Thomas R., et al.. (2000). A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.. PubMed. 9(1). 81–7. 43 indexed citations
8.
Hoffman, Richard M., et al.. (1996). Inhibition of angiogenesis and murine tumour growth by laminarin sulphate. British Journal of Cancer. 73(10). 1183–1186. 24 indexed citations
9.
Hoffman, Richard M., D. Paper, Jane Donaldson, Susanne Alban, & Gerhard Franz. (1995). Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation. Journal of Cell Science. 108(11). 3591–3598. 25 indexed citations
11.
Workman, Paul, et al.. (1987). High-performance liquid chromatography of chlorambucil analogues. Journal of Chromatography B Biomedical Sciences and Applications. 422. 315–321. 3 indexed citations
12.
Workman, Paul, et al.. (1986). CB 1954 revisited. Cancer Chemotherapy and Pharmacology. 16(1). 9–14. 17 indexed citations
13.
Honess, Davina J., Jane Donaldson, Paul Workman, & N M Bleehen. (1985). The effect of systemic hyperthermia on melphalan pharmacokinetics in mice. British Journal of Cancer. 51(1). 77–84. 21 indexed citations
14.
Donaldson, Jane, et al.. (1978). Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(3). 439–43. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026